Keros Therapeutics, Inc. revenue breakdown overview

Keros Therapeutics, Inc. revenue for the last year amounted to 3.55 M USD, the most of which — 3.55 M USD — came from its highest performing source at the moment, Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders, the year earlier bringing 151.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Keros Therapeutics, Inc. 3.55 M USD, and the year before that — 151.00 k USD.